Shinko Asset Management Company’s Regeneron Pharmaceuticals REGN Stock Holding History

Shinko Asset Management Company’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$80K	Hold	200	–	–	﹤0.01%	440
2016 Q2	$70K	Hold	200	–	–	﹤0.01%	458
2016 Q1	$72K	Sell	200 -13	-6%	-$5.36K	﹤0.01%	444
2015 Q4	$116K	Hold	213	–	–	﹤0.01%	393
2015 Q3	$99K	Sell	213 -9	-4%	-$4.83K	﹤0.01%	406
2015 Q2	$113K	Sell	222 -26	-10%	-$12.7K	﹤0.01%	320
2015 Q1	$112K	Sell	248 -79	-24%	-$33.5K	﹤0.01%	259
2014 Q4	$134K	Hold	327	–	–	﹤0.01%	254
2014 Q3	$118K	Hold	327	–	–	﹤0.01%	285
2014 Q2	$92K	Hold	327	–	–	﹤0.01%	340
2014 Q1	$98K	Sell	327 -25	-7%	-$7.7K	﹤0.01%	315
2013 Q4	$97K	Sell	352 -48	-12%	-$13.8K	﹤0.01%	326
2013 Q3	$125K	Hold	400	–	–	﹤0.01%	273
2013 Q2	$90K	Buy	+400	New	+$93.1K	﹤0.01%	326

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Shinko Asset Management Company's REGN Position: Q3 2016 in Review

Shinko Asset Management Company held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2016 at 200 shares worth $80K. The position accounts for ﹤0.01% of the portfolio, ranked #440.

Shinko Asset Management Company first reported a position in REGN in Q2 2013 and has held it in 14 quarters since. The position peaked at $134K in Q4 2014. 554 funds tracked by Wall St. Rank hold REGN as of Q3 2016.

Shinko Asset Management Company held 200 shares of Regeneron Pharmaceuticals worth $80K as of Q3 2016.
Shinko Asset Management Company left its Regeneron Pharmaceuticals share count unchanged in Q3 2016.
Regeneron Pharmaceuticals made up ﹤0.01% of Shinko Asset Management Company's portfolio in Q3 2016, its #440 holding.
Shinko Asset Management Company first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
Shinko Asset Management Company's Regeneron Pharmaceuticals position peaked at $134K in Q4 2014.
554 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2016.

Based on Shinko Asset Management Company's 13F filing for Q3 2016, filed 24 Oct 2016.